oder geht es nochmal ein stock tiefer ???
bin mal gespannt
bin mal gespannt
|
Chimerix CEO Michelle Berrey charts course after trials for its signature drug is halted
This study shows that brincidofovir had a clear antiviral effect, preventing cytomegalovirus reactivation particularly in patients at higher risk for CMV infection,” said Dr. Francisco Marty of Dana-Farber Cancer Institute in Boston in a press release distributed by Chimerix. Marty was the lead investigator for the drug.
www.bizjournals.com/bizwomen/news/...ourse-after.html?page=all
|